Varex Imaging

Varex Imaging Corp. engages in the design, manufacture, and sale of imaging components. It operates through the Medical and Industrial segments. The Medical segment delivers and services x-ray imaging components, including X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, and three-dimensional reconstruction software. The Industrial segment offers x-ray imaging products for use in security, and nondestructive testing and inspection applications. The company was founded in July 2016 and is headquartered in Salt Lake City, UT.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Varex Imaging meets Q1 expectations amidst gross margin challenges

Varex Imaging's Q1 performance met expectations, with revenue impacted by a less favorable product mix. The company faces challenges from cautious customer behavior and gross margin pressures but sees opportunities in the healthcare market, particularly in China.

Varex Imaging excels in Q2, plans expansion amid supply challenges

Varex Imaging delivered strong Q2 results, driven by robust performance in the Industrial segment and innovative projects in Medical and Industrial segments.
While facing supply chain challenges, the company aims to invest in expanding manufacturing capacity to address demand and ensure operational resilience.
With a positive outlook for fiscal 2023 and a focus on cost management, Varex is poised for continued growth and market leadership in the imaging industry.

Varex Imaging achieves record revenue in Q3 2023 earnings

Varex Imaging delivered a robust performance in Q3 2023, marked by record revenue, improved margins, and strong segment growth.
While facing supply chain and market challenges, the company remains optimistic about sustained growth and profitability.
Strategic focus on new products, margin enhancement, and key segment expansion positions Varex well for future success.

Varex Imaging posts strong Q4 results, eyes growth opportunities

Varex Imaging reports solid Q4 performance with revenue driven by Industrial segment. Challenges include decline in Medical segment revenue and anticipated revenue decrease in Q1 FY 2024. Company focuses on growth opportunities in photon counting technology, India expansion, and new product introductions.

Varex Imaging meets Q1 expectations, focuses on photon counting growth

Varex Imaging's Q1 performance met expectations, with revenue at $190 million and a focus on new product development in photon counting technology.
While facing challenges in certain modalities and markets, the company showcased strength in global Industrial sales and employee pride.
Opportunities lie in the photon counting technology for CT, revenue growth expectations for Q2, and stable operational environment post-supply chain issues.
Management's forward-looking approach towards customer successes and technology advancements positions Varex Imaging for future growth and market expansion.

Varex Imaging faces revenue challenges in China, eyes tech growth

Varex Imaging's Q2 performance reflected mixed results with revenue, gross margin, and EPS figures. While facing challenges from soft demand in China, the company is focusing on leveraging photon-counting technology for future growth opportunities.

Varex Imaging meets Q3 revenue expectations amidst market challenges

Varex Imaging's Q3 performance was solid, with strengths in cargo inspection products and financial stability.
Challenges in China and the Medical segment require strategic focus for sustained growth.
Opportunities lie in market improvements, managing demand effectively, and exploring new growth avenues.

Varex Imaging reports resilient Q4 performance and outlines growth strategies

Varex Imaging's Q4 performance showcased revenue resilience in the industrial segment but faced challenges in medical segment revenue.
The company's strategic focus on innovation and expansion presents growth opportunities in dynamic markets.
Balancing revenue diversification, margin maintenance, and operational efficiency will be key for future success.
Anticipated revenue growth in Q1 2025 with a range of $195-215 million and varied EPS expectations.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Varex Imaging Corp. engages in the design, manufacture, and sale of imaging components. It operates through the Medical and Industrial segments. The Medical segment delivers and services x-ray imaging components, including X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, and three-dimensional reconstruction software. The Industrial segment offers x-ray imaging products for use in security, and nondestructive testing and inspection applications. The company was founded in 2016 and is headquartered in Salt Lake City, UT.

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced it has priced a private offering (the “Offering”) of $125 million aggregate principal amount of 7.875% senior secured notes due October 15, 2027 (the “notes”) at an offering price of 101.5% of the principal amount thereof, plus accrued and unpaid interest from October 15, 2024. The notes offered hereby will be issued as “Additional Notes” under the Indenture and will constitute a further issuance of our 7.

Varex Announces Pricing of Private Offering of $125 Million of Senior Secured Notes

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced that its 2025 Annual Meeting of Stockholders will be held in virtual format only at 4:30 pm Mountain Time on Thursday, February 13, 2025. Stockholders will not be able to attend the 2025 annual meeting in person. Varex stockholders of record at the close of business on December 16, 2024 will be entitled to receive notice of the Annual Meeting and to vote upon matters considered at the meeting. Varex will m.

Varex to Hold Virtual Annual Meeting of Stockholders and Sets Annual Meeting and Record Dates

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) is proud to introduce the LUMEN HD and LUMEN HD Pro digital radiography detectors, designed to meet the evolving standards of healthcare imaging. As the demands of medical imaging continue to shift, these detectors are built to offer reliable, fast, and user-friendly performance in today's cost-conscious environment. Key Features and Benefits: Reliable. The LUMEN family of detectors are designed for uninterrupted flow of.

Varex Introduces LUMEN HD and LUMEN HD Pro: Radiography Detectors Built for the New Demands in Imaging

Varex Imaging Corporation (NASDAQ:VREX ) Q4 2024 Earnings Conference Call November 19, 2024 5:00 PM ET Company Participants Christopher Belfiore - Director of Investor Relations Sunny Sanyal - President and Chief Executive Officer Shubham Maheshwari - Chief Financial Officer Conference Call Participants Suraj Kalia - Oppenheimer & Co Kyle Bauser - B. Riley Securities Jim Sidoti - Sidoti & Company Larry Solow - CJS Securities Operator Greetings, and welcome to the Varex Fourth Quarter Fiscal Year 2024 Earnings Call.

Varex Imaging Corporation (VREX) Q4 2024 Earnings Call Transcript

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the fourth quarter and fiscal year 2024. Q4 FY24 Summary Revenues of $206 million GAAP gross margin 33% | Non-GAAP gross margin* 33% GAAP operating expense $56 million | Non-GAAP operating expense* $53 million GAAP operating margin 5% | Non-GAAP operating margin* 7% GAAP net earnings $(1.22) per diluted share | Non-GAAP net earnings* $0.19 per diluted share Cash flow fro.

Varex Announces Financial Results for Fourth Quarter and Fiscal Year 2024

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the fourth quarter and full fiscal year 2024 following the close of regular trading on Tuesday, November 19, 2024. The earnings news release will be followed by a conference call at 3:00 pm Mountain Time that day. This call will be webcast live and can be accessed at the company's website at www.vareximaging.com/investor-relations/. Investors can also acc.

Varex Schedules Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call

Varex Imaging Corporation (NASDAQ:VREX ) Q3 2024 Results Conference Call August 1, 2024 5:00 PM ET Company Participants Christopher Belfiore - Director of Investor Relations Sunny Sanyal - President and Chief Executive Officer Sam Maheshwari - Chief Financial Officer Conference Call Participants Young Li - Jefferies Jim Sidoti - Sidoti & Company Young Li - Jefferies Operator Greetings. Welcome to the Varex Imaging Third Quarter Fiscal Year '24 Earnings Call.

Varex Imaging Corporation (VREX) Q3 2024 Earnings Call Transcript

VAREX IMAGING (VREX) came out with quarterly earnings of $0.14 per share, missing the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.37 per share a year ago.

VAREX IMAGING (VREX) Lags Q3 Earnings and Revenue Estimates

SALT LAKE CITY--(BUSINESS WIRE)--Varex Announces Financial Results for Third Quarter Fiscal Year 2024.

Varex Announces Financial Results for Third Quarter Fiscal Year 2024

Eventbrite

Planet Image International Ltd

Stocks near 52-week lows may feel like incredible bargains, but the savvy should recognize the risks. Dumping these stocks is a strategic move, especially when they continue to trend downward, offering little to no upside potential ahead.

Sell Alert: 3 Stocks to Offload Near 52-Week Lows

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the third quarter of fiscal year 2024 following the close of regular trading on Thursday, August 1, 2024. The earnings news release will be followed by a conference call at 3:00 pm Mountain Time that day. This call will be webcast live and can be accessed at the company's website at www.vareximaging.com/investor-relations/. Investors can also access this.

Varex Schedules Third Quarter Fiscal Year 2024 Earnings Release and Conference Call

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to participate in the following upcoming investor conferences. Jefferies Global Healthcare Conference in New York – June 6, 2024 at 9:00am ET Goldman Sachs 45th Annual Global Healthcare Conference in Miami – June 10, 2024 (1x1 only) Sidoti June 2024 Virtual Small Cap Conference – June 13, 2024 at 10:45am ET These events can be accessed at the Varex Imaging website: www.varexima.

Varex Management to Participate in Upcoming Investor Conferences

Varex Imaging Corporation (NASDAQ:VREX ) Q2 2024 Earnings Conference Call May 2, 2024 5:00 PM ET Company Participants Chris Belfiore – Director of Investor Relations Sunny Sanyal – President and Chief Executive Officer Sam Maheshwari – Chief Financial Officer Conference Call Participants Shaymus Contorno – Oppenheimer Young Li – Jefferies James Sidoti – Sidoti & Company Larry Solow – CJS Operator Greetings and welcome to the Varex Imaging Second Quarter Full Year 2024 Earnings Call. At this time all participants are in a listen-only mode.

Varex Imaging Corporation (VREX) Q2 2024 Earnings Call Transcript

VAREX IMAGING (VREX) came out with quarterly earnings of $0.16 per share, missing the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.26 per share a year ago.

VAREX IMAGING (VREX) Q2 Earnings Lag Estimates

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the second quarter of fiscal year 2024. 2QFY24 Summary Revenues $206 million GAAP gross margin 32% | Non-GAAP gross margin* 33% GAAP operating margin 4% | Non-GAAP operating margin* 6% GAAP net earnings $0.03 per diluted share | Non-GAAP net earnings* $0.16 per diluted share Cash flow from operations was $3 million "Revenue of $206 million in the second quarter was in li.

Varex Announces Financial Results for Second Quarter Fiscal Year 2024

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the second quarter of fiscal year 2024 following the close of regular trading on Thursday, May 2, 2024. The earnings news release will be followed by a conference call at 3:00 pm Mountain Time that day. This call will be webcast live and can be accessed at the company's website at www.vareximaging.com/investor-relations/. Investors can also access this co.

Varex Schedules Second Quarter Fiscal Year 2024 Earnings Release and Conference Call

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced it has entered into a senior secured revolving credit agreement (the “RLOC Facility”) for an initial aggregate principal amount of up to $155 million. Zions Bancorporation, N.A. (“Zions”) acted as lead arranger and bookrunner for the new RLOC Facility. Simultaneously, Varex terminated its existing senior secured asset-based revolving credit agreement. “We are pleased to have successfully closed the revolvi.

Varex Announces Closing of Revolving Credit Facility of $155 Million

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to present at the Oppenheimer 34th Annual Healthcare MedTech & Services Virtual Conference. Management will be participating in a fireside chat on Tuesday, March 12, 2024 at 1:20pm EDT. The webcast can be accessed here or on Varex's website at www.vareximaging.com/news. About Varex Varex Imaging Corporation is a leading innovator, designer and manufacturer of X-ray imaging.

Varex to Present at Oppenheimer 34th Annual Healthcare MedTech & Services Virtual Conference

Varex Imaging Corporation (VREX) Q1 2024 Earnings Call Transcript

VAREX IMAGING (VREX) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.08 per share a year ago.

VAREX IMAGING (VREX) Lags Q1 Earnings Estimates

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the first quarter of fiscal year 2024. 1QFY24 Summary Revenues $190 million GAAP gross margin 30% | Non-GAAP gross margin* 31% GAAP operating margin 2% | Non-GAAP operating margin* 5% GAAP net loss $0.01 per diluted share | Non-GAAP net earnings* $0.06 per diluted share Cash flow from operations was $10 million “Revenue of $190 million in the first quarter of fiscal 2024.

Varex Announces Financial Results for First Quarter Fiscal Year 2024

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the first quarter of fiscal year 2024 following the close of regular trading on Tuesday, February 6, 2024. The earnings news release will be followed by a conference call at 3:00 pm Mountain Time that day. This call will be webcast live and can be accessed at the company's website at www.vareximaging.com/investor-relations/. Investors can also access this.

Varex Schedules First Quarter Fiscal Year 2024 Earnings Release and Conference Call

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to present at CJS Securities 24th Annual New Ideas for the New Year Virtual Conference. Management will be presenting on Wednesday, January 10, 2024 at 3:05pm EST. Further details of the conference can be found on Varex's website at www.vareximaging.com/news. About Varex Varex Imaging Corporation is a leading innovator, designer and manufacturer of X-ray imaging components, whi.

Varex to Present at CJS Securities 24th Annual New Ideas for the New Year Virtual Conference

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to participate in two upcoming investor conferences. 6th Annual Evercore ISI HealthCONx Conference – November 30, 2023 (Fireside chat & 1x1s) Mizuho Medical Devices & Healthcare Services Summit 2023 – December 6, 2023 (Virtual 1x1s). More details can be accessed through Varex's website at www.vareximaging.com/news on the dates listed above. About Varex Varex Imaging Cor.

Varex to Participate in Two Investor Conferences

Varex Imaging Corporation (NASDAQ:VREX ) Q4 2023 Earnings Conference Call November 14, 2023 5:00 PM ET Company Participants Christopher Belfiore – Director-Investor Relations Sunny Sanyal – President and Chief Executive Officer Sam Maheshwari – Chief Financial Officer Conference Call Participants James Sidoti – Sidoti & Company Larry Solow – CJS Suraj Kalia – Oppenheimer Anthony Petrone – Mizuho Operator Greetings, and welcome to the Varex Fourth Quarter and Fiscal Year 2023 Earnings Call. At this time, all participants are in a listen-only mode.

News for Varex Imaging Stock (VREX)